{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040275","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.880821+00:00","generated_at":"2026-05-30T19:40:05.621397+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sanara MedTech appoints former LHC Group CEO Keith Myers to board; James Stuckert resigns as director","bullets":["James W. Stuckert resigned as director effective Oct 4, 2024; will remain as Director Emeritus in non-voting advisory capacity.","Keith Myers appointed to board; he co-founded LHC Group and served as chairman/CEO until LHC's merger with Optum in 2023.","Myers will serve on Corporate Development Committee; receives $90k annual board retainer and $5k committee fee under standard policy.","Stuckert's resignation was not due to any disagreement with the company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040275","json":"https://secwatch.observer/filing/0001493152-24-040275.json","markdown":"https://secwatch.observer/filing/0001493152-24-040275.md","text":"https://secwatch.observer/filing/0001493152-24-040275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:40:05.621397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f5b529980","claim":"James W. Stuckert resigned as Director at Sanara MedTech Inc..","evidence_excerpt":"On October 4, 2024, James W. Stuckert notified Sanara MedTech Inc. (the “Company”) of his intention to resign from his position as a member of the Company’s Board of Directors (the “Board”) and each of its committees upon which he serves, effective as of October 4, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ba82ddcf2a","claim":"Keith Myers was appointed as Director at Sanara MedTech Inc..","evidence_excerpt":"On October 4, 2024, the Board appointed Keith Myers as a director of the Company, effective October 4, 2024 (the “Effective Date”), to fill the vacancy resulting from Mr. Stuckert’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}